We are live on !
Find out more
HighMark Wealth Management Portfolio holdings
AUM
$299M
Turnover
13.67%
1-Year Est. Return
53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.69%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
(+22%)
Cap. Flow
+$8.26M
Cap. Flow % of AUM
Cap. Flow %
2.77%
Top 10 Holdings %
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held
Equity + Options
3.4
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$18.3M |
| 2 |
SI-BONE Inc
SIBN
|
+$3.79M |
| 3 |
Duos Technologies
DUOT
|
+$2.91M |
| 4 |
Apogee Therapeutics
APGE
|
+$2.91M |
| 5 |
Neuropace
NPCE
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$9.41M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$5.14M |
| 3 |
AnaptysBio
ANAB
|
+$3.29M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.64M |
| 5 |
Piper Sandler
PIPR
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.9% |
| 2 | Healthcare | 21.84% |
| 3 | Technology | 4.77% |
| 4 | Financials | 3.58% |
| 5 | Industrials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
Corteva
CTVA
$7.94B
| $7.47K | ﹤0.01% |
88
+50
| +132% | +$4.02K |
2019 Q4
26 quarters
|
|
352
Hewlett Packard
HPE
$59.4B
| $7.44K | ﹤0.01% |
+165
| New | +$5.96K |
2026 Q2
0 quarters
|
|
353
Amgen
AMGN
$249B
| $7.24K | ﹤0.01% |
20
| – | – |
2019 Q4
26 quarters
|
|
354
Baidu
BIDU
$27.9B
| $7.2K | ﹤0.01% |
63
| – | – |
2019 Q4
26 quarters
|
|
355
iShares MSCI USA Value Factor ETF
VLUE
$8.81B
| $6.97K | ﹤0.01% |
35
| – | – |
2025 Q2
4 quarters
|
|
356
Hilton Worldwide Holdings Inc. Common Stock
HLT
$82.4B
| $6.94K | ﹤0.01% |
21
| – | – |
2026 Q1
1 quarter
|
|
357
iShares MSCI USA Momentum Factor ETF
MTUM
$3.98B
| $6.92K | ﹤0.01% |
80
| – | – |
2025 Q2
4 quarters
|
|
358
ConocoPhillips
COP
$161B
| $6.86K | ﹤0.01% |
66
-34
| -34% | -$4.03K |
2026 Q1
1 quarter
|
|
359
British American Tobacco
BTI
$131B
| $6.86K | ﹤0.01% |
111
+32
| +41% | +$1.93K |
2026 Q1
1 quarter
|
|
360
Diamondback Energy
FANG
$50B
| $6.86K | ﹤0.01% |
+39
| New | +$7.57K |
2026 Q2
0 quarters
|
|
361
Parker-Hannifin
PH
$116B
| $6.85K | ﹤0.01% |
7
-2
| -22% | -$1.83K |
2024 Q1
9 quarters
|
|
362
TKO Group
TKO
$13.8B
| $6.64K | ﹤0.01% |
33
| – | – |
2025 Q3
3 quarters
|
|
363
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.31B
| $6.6K | ﹤0.01% |
+150
| New | +$6.6K |
2026 Q2
0 quarters
|
|
364
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.41B
| $6.56K | ﹤0.01% |
55
+1
| +2% | +$121 |
2025 Q2
4 quarters
|
|
365
Quanta Services
PWR
$81.5B
| $6.48K | ﹤0.01% |
9
| – | – |
2022 Q2
16 quarters
|
|
366
iShares International Equity Factor ETF
INTF
$3.64B
| $6.4K | ﹤0.01% |
156
+2
| +1% | +$82 |
2025 Q2
4 quarters
|
|
367
Ross Stores
ROST
$73.8B
| $6.38K | ﹤0.01% |
30
-17
| -36% | -$3.82K |
2025 Q4
2 quarters
|
|
368
AB InBev
BUD
$165B
| $6.34K | ﹤0.01% |
77
-14
| -15% | -$1.1K |
2025 Q1
5 quarters
|
|
369
Avery Dennison
AVY
$14.1B
| $6.33K | ﹤0.01% |
39
+15
| +63% | +$2.44K |
2025 Q3
3 quarters
|
|
370
Interactive Brokers
IBKR
$34.4B
| $6.27K | ﹤0.01% |
72
+15
| +26% | +$1.25K |
2026 Q1
1 quarter
|
|
371
Defi Technologies
DEFT
$131M
| $6.17K | ﹤0.01% |
12,000
| – | – |
2025 Q2
4 quarters
|
|
372
Axon Enterprise
AXON
$25.4B
| $6.17K | ﹤0.01% |
+11
| New | +$4.6K |
2026 Q2
0 quarters
|
|
373
Prudential Financial
PRU
$40.9B
| $6.15K | ﹤0.01% |
57
-86
| -60% | -$8.74K |
2025 Q2
4 quarters
|
|
374
Aptiv
APTV
$7.98B
| $6.14K | ﹤0.01% |
100
| – | – |
2025 Q2
4 quarters
|
|
375
Horizon Kinetics Medical ETF
MEDX
$17.7M
| $6.13K | ﹤0.01% |
167
| – | – |
2023 Q1
13 quarters
|
|
Similar funds
BOC
HighMark Wealth Management's Q2 2026 Portfolio in Review
As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.
- HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
- HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
- HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
- HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
- HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
- HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
- HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.